Holdings
Health Sciences Trust
As of Jun 30, 2026, Health Sciences Trust reported 161 positions worth US$247M. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 29,965 | US$35.9M | +4,757 | Jun 30, 2026 |
| Johnson & Johnson | 62,593 | US$15.9M | +39,621 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 35,965 | US$14.9M | +9,656 | Jun 30, 2026 |
| Abbvie Inc. | 52,771 | US$13.3M | +22,646 | Jun 30, 2026 |
| Merck & Company, Inc. | 82,388 | US$10.6M | +16,700 | Jun 30, 2026 |
| Gilead Sciences, Inc. | 58,630 | US$7.41M | +15,530 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 13,365 | US$6.7M | −5,687 | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 12,026 | US$5.97M | −502 | Jun 30, 2026 |
| Bristol-myers Squibb Company | 96,837 | US$5.58M | new | Jun 30, 2026 |
| Abbott Laboratories | 55,400 | US$5.03M | new | Jun 30, 2026 |